Cancer drugs could enter clinical trials and ultimately reach cancer patients faster thanks to legal contract templates created by the CEO Roundtable on Cancer.
Contract research organisation PPD will have to forego a scheduled $25m payment from Takeda of Japan in the fourth quarter after the US Food and Drug Administration (FDA) held up approval of a product for diabetes.
US-based contract research organisation Medelis has founded a European division, Medelis Europe, to bring its expertise in oncology clinical trials design and management to customers wanting to launch drugs in Europe.
PPD has been selected as the full-service preferred provider for translational clinical development services by the Juvenile Diabetes Research Foundation (JDRF).
Contract research organisation Encorium has bought $250,000 of its own stock in a bid to stabilise its share price, which has been in steep decline in recent weeks.
Mere weeks after signing major strategic collaborations with contract service firms Covance, Quintiles and 3i, Eli Lilly has journeyed further down the outsourcing route – albeit with a different spin – by forging another agreement with India’s Jubilant...
Canada’s Ethica Clinical Research has expanded into the emerging Latin American market via a joint venture with Argentinean contract research organisation Blanchard y Asociados.
Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.
US contract research organisation Encorium Group has postponed its planned acquisition of Prologue Research International and cut staff in the latest twist in a rollercoaster ride for the firm in recent weeks.
Clinical trials that support the effectiveness of drugs filed for approval in the US are more likely to be published than those that are less supportive, according to researchers at the University of California at San Francisco.
US CRO group Encorium has signed new contracts worth around $6.2m (€4.1m) under which it will conduct trials of a developmental vaccine on behalf of a global biopharmaceutical company.
China is the ideal destination for outsourcing, according to a report by PricewaterhouseCoopers (PwC) that has calculated rankings based on a range of parameters.
Patient recruitment specialist Acurian has hit a major milestone in its business, with more than half of the entire US population of type 2 diabetics now opted into its database.
Shifting clinical trial operations from Western markets to India can reap substantial benefits for sponsors in saved costs and time, according to KPMG’s just-published report India Pharma Inc.
Quintiles Transnational Corp has announced an expansion of its operations in Singapore in order to meet what it described as “surging demand” in the Asia-Pacific region.
Drug development services company PharmaNet saw its share price slashed in half on Friday after downsizing its 2008 revenues and earnings forecasts for the second time this year.
The outsourcing of Phase I trials to India may be allowed by 2009-10 after the Central Drugs Standard Control Organisation (CDSCO) said it is considering changing its stance.
Parexel has trimmed back its earnings guidance for the first quarter of fiscal 2009 as it starts the process of integrating ClinPhone, which the company bought for £91m (€114m) last month.
Beleaguered life science tools and services company MDS Inc, has recorded disappointing third quarter results, with revenues from its Analytical Technologies and MDS Pharma Services divisions missing forecasts.
eClinical specialist Phase Forward has added to its portfolio by purchasing interactive-response technology company Clarix for $40m in cash in a move aimed at toppling ClinPhone from its leading position in the sector.
Recent developments in the clinical research sector include an acquisition by Canada’s Algorithme, a Dutch CRO looking to push into the North American market, and a £20m boost for UK clinical research.
Merck & Co has been accused of carrying out clinical trials of its Vioxx (rofecoxib) painkiller that were designed primarily for marketing purposes rather than to answer a clinical hypothesis.
Contrary to fears, the European Union’s Clinical Trials Directive has not had an inhibitory effect on the number of studies carried out by publicly-funded researchers, at least in Denmark.
US trial firm ACRI and contract research organisation (CRO) Clinesian have teamed up to target the pharmaceutical sector’s ever growing demand for integrated clinical development capacity.
Contract research organisation Chiltern International has finalised the reorganisation of its early-stage clinical development activities, following its acquisition of Drug Development Solutions in February.
The revelation that 49 infants died during clinical trials in India has sparked anger among the nation’s congress, with some calling for all studies to be stopped while investigations take place despite the trials having an infant mortality rate (IMR)...
in-PharmaTechnologist.com presents its round up of the latest developments in contract research, including CTI partnering to access Latin America, Encorium signing contracts worth $13.5m and Omnicare setting up in Sweden.
Kendle has posted a sprightly 30 per cent increase in service revenues in the second quarter, bringing in $127m, well ahead of forecasts and providing further evidence of the buoyancy of the contract research market.
ICON has introduced an electronic Patient Recorded Outcomes (ePRO) module that could slash weeks off the time it takes to implement the technology in clinical trials.
PharmaNet has reported a stellar set of second-quarter results, reversing its year-earlier loss with a $2.2m profit that was driven by a good performance by the firm’s early-stage development business.
Outsourcing-Pharma.com provides its periodic round-up of developments in the eClinical space, including a tough decision for Datatrak, news of a new contract for Medidata , a recruitment package from HMS and cardiac data certification for specialty CRO...
Like many of its peers in the contract clinical research sector, data management specialist Phase Forward put in another bumper financial performance in the second quarter headed by a 30 per cent hike in revenues to $41m.
Pharmaceutical Product Development (PPD) reported a bumper set of second quarter figures, well ahead of analysts expectations, but saw its share price take a dip anyway.
ClinPhone's shareholders have now approved the acquisition of the company by Parexel after rival Quintiles withdrew from the race to buy the eClinical technology company.
Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits for the second quarter, despite a challenging operating environment that pegged back sales growth.
The pharmaceutical industry’s poor reputation among the public, a lack of understanding of clinical research and the increasing complexity of trials are all problems affecting patient recruitment, but greater use of the Internet could be a solution, according...
Life science tools and services company MDS Inc has said it will cut about 210 jobs at two of its divisions - its MDS Pharma Services and MDS Analytical Technologies – in a bid to reduce costs by around $20m a year.
Acquisitive Indian contract research organisation Veeda has added
another company to its portfolio, buying International Oncology
Network (ION) of the US.
Contract research organisation MDS Pharma Services has launched a
new version of its ClinQuick electronic data capture (EDC) system
designed to help in the design and management of Phase I clinical
studies.
A service provider called Binto is filling a much needed vacuum in the clinical trial industry in terms of patient tracking, eliminating the need for big pharmaceutical firms to resort to methods such as hiring private investigators to track down "lost"...
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving PPD, PRA
International, SpineMark and Pacific Biometrics.
Ireland's Almac Group has announced the creation of a new oncology
division that will focus on the discovery and development of "novel
and innovative" approaches to treatment in this key disease area.